14159 capital (GP), LLC
CIK 1317493 · last filed 2012-03-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$46.70M
Companies
13
Total Filings
59
Lifetime Open-Market Net
$6.15M
Filer Profile
Reported Address
667 MADISON AVE21ST FLOOR
NEW YORK, NY 10065
Phone
(212) 339-5600
State of Incorporation
DE
Formerly Known As
14159 Capital (GP, LLC (2005–2005)
Related Filers
JULIAN BAKER — 216 joint filings, latest 2012-03-14
FELIX BAKER — 203 joint filings, latest 2012-03-14
INCYTE CORP — 28 joint filings, latest 2012-01-17
Baker / Tisch Capital (GP), LLC — same reported address
Baker Biotech Capital (GP), LLC — same reported address
Baker Bros. Capital (GP), LLC — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
View filings on SEC EDGAR.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ocera Therapeutics, Inc. (TZYM) Delisted | 10%+ Owner | 4,609 | — | — | $243.5K | 1 | 2012-03-14 |
| GENOMIC HEALTH INC (GHDX) Delisted | Director | 215,669 | — | — | $4.35M | 15 | 2012-02-29 |
| INCY | Director | 344,064 | $125.54 | $43.19M | -$303.0K | 12 | 2012-01-17 |
| Seagen Inc. (SGEN) Delisted | Director | 323,148 | $228.74 | $73.92M | $2.01M | 5 | 2011-09-08 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | 10%+ Owner | 143,568 | — | — | -$430.3K | 3 | 2011-08-03 |
| Ardea Biosciences, Inc./DE (RDEA) Delisted | Director | 93,282 | — | — | $801.3K | 2 | 2011-01-24 |
| RPRX | 10%+ Owner | 38,386 | $60.14 | $2.31M | $49.1K | 1 | 2010-04-28 |
| BCRX | 10%+ Owner | 128,783 | $9.28 | $1.20M | -$200.9K | 1 | 2009-06-01 |
| VIROPHARMA INC (VPHM) Delisted | 10%+ Owner | 187,491 | — | — | -$467.3K | 4 | 2009-05-26 |
| Aceragen, Inc. (IDRA) Delisted | 10%+ Owner | 928 | $7.22 | $6.7K | -$112.9K | 2 | 2008-07-21 |
| ALLOS THERAPEUTICS INC (ALTH) Delisted | 10%+ Owner | 264,699 | — | — | $309.2K | 3 | 2008-05-27 |
| TAPESTRY PHARMACEUTICALS, INC (TPPH) Delisted | 10%+ Owner | 112,451 | — | — | -$473 | 1 | 2008-04-08 |
| Aceragen, Inc. (IDP) Delisted | 10%+ Owner | 31,708 | — | — | -$101.7K | 3 | 2007-12-07 |
Recent Filings · Page 5 of 6
59 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-02-21 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Buy (P) | +24,030 | $152.4K | EDGAR |
| 2008-02-11 | Seagen Inc. (SGEN) Delisted | Buy (P) | +14,649 | $132.1K | EDGAR |
| 2008-01-24 | INCY | Buy (P) | +21 | $223 | EDGAR |
| 2008-01-11 | INCY | Buy (P) | +11,673 | $127.7K | EDGAR |
| 2008-01-10 | VIROPHARMA INC (VPHM) Delisted | Buy (P) | +16,536 | $146.1K | EDGAR |
| 2008-01-04 | Aceragen, Inc. (IDRA) Delisted | Sell (S) | −4,782 | -$62.4K | EDGAR |
| 2007-12-12 | INCY | Buy (P) | +27,538 | $275.1K | EDGAR |
| 2007-12-07 | Aceragen, Inc. (IDP) Delisted | Sell (S) | −4,221 | -$52.0K | EDGAR |
| 2007-12-06 | INCY | Buy (P) | +3,624 | $32.6K | EDGAR |
| 2007-11-21 | INCY | Buy (P) | +17,628 | $144.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.